Advertisement

Topics

Lundbeck to take equity stake in Proximagen

08:01 EDT 30 Sep 2011 |

Published with kind permission of MEDNOUS. H. Lundbeck A/S has decided to invest £10.3 million in Proximagen Group Plc of the UK in the second alignment of companies involved in the CNS research space this week. The first was Biotie Therapies Corp’s announcement on 27 September of plans to acquire Newron Pharmaceuticals SpA. Under the [...]

Original Article: Lundbeck to take equity stake in Proximagen

NEXT ARTICLE

More From BioPortfolio on "Lundbeck to take equity stake in Proximagen"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...